CAMP4 Therapeutics Corporation CAMP IPO will take place October, 11 on the NASDAQ exchange under the ticker CAMP.
The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on April 09, 2025.
See also: Benzinga IPO Calendar
About CAMP4 Therapeutics Corporation
CAMP4 Therapeutics Corporation is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
